AXSM - Axsome Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$255.81
DETAILS
HIGH:
$302.00
LOW:
$200.00
MEDIAN:
$259.50
CONSENSUS:
$255.81
UPSIDE:
8.41%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue | 638.5 | 385.7 | 270.6 | 50.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 47.5 | 33.3 | 26.1 | 5.2 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 |
| Gross Profit | 591.0 | 352.4 | 244.5 | 44.8 | 0 | 0 | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | 0 | 0 |
| Operating Expenses | |||||||||||||
| R&D Expenses | 183.3 | 187.1 | 97.9 | 57.9 | 58.1 | 70.2 | 53.6 | 23.5 | 20.0 | 21.2 | 6.8 | 4.3 | 1.5 |
| SG&A Expenses | 570.6 | 411.4 | 323.1 | 159.3 | 66.6 | 28.9 | 13.6 | 9.4 | 7.2 | 6.3 | 2.4 | 1.4 | 0.3 |
| Other Expenses | 6.4 | 34.5 | 55.3 | 7.4 | 0 | (0.1) | (0.1) | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 760.3 | 633.0 | 476.4 | 224.6 | 124.7 | 99.1 | 67.1 | 32.8 | 27.2 | 27.5 | 9.2 | 5.7 | 1.8 |
| Operating Income | |||||||||||||
| Operating Income | (169.2) | (280.6) | (231.8) | (179.8) | (124.7) | (99.1) | (67.2) | (32.8) | (27.2) | (27.5) | (9.2) | (5.7) | (1.8) |
| Interest Expense | 6.6 | 6.6 | 6.5 | 7.3 | 5.7 | 2.6 | 1.2 | 1.1 | 1.3 | 0.1 | 0.9 | 2.2 | 0.3 |
| Interest Income | 9.4 | 0 | 0 | 0 | 0 | 2.6 | 1.2 | 0 | 0 | 0 | 0.9 | 2.2 | 0 |
| Profitability | |||||||||||||
| EBITDA | (168.1) | (272.6) | (225.0) | (175.4) | (124.6) | (100.3) | (67.2) | (32.6) | (27.8) | (27.5) | (9.2) | (2.7) | 0 |
| EBIT | (177.1) | (280.6) | (231.8) | (179.8) | (124.7) | (100.4) | (67.2) | (32.6) | (27.8) | (27.5) | (9.2) | (6.2) | (1.8) |
| Income Before Tax | (183.7) | (287.1) | (238.3) | (187.1) | (130.4) | (102.9) | (68.3) | (31.0) | (28.9) | (27.2) | (10.6) | (6.0) | (2.2) |
| Income Tax Expense | (0.5) | 0.1 | 1.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.4 | 0 | 0 |
| Net Income | (183.2) | (287.2) | (239.2) | (187.1) | (130.4) | (102.9) | (68.3) | (31.0) | (28.9) | (27.2) | (12.2) | (6.0) | (2.2) |
| Per Share Data | |||||||||||||
| EPS (Basic) | -3.68 | -5.99 | -5.27 | -4.60 | -3.47 | -2.83 | -2.05 | -1.15 | -1.27 | -1.42 | -0.88 | -0.47 | -0.28 |
| EPS (Diluted) | -3.68 | -5.99 | -5.27 | -4.60 | -3.47 | -2.83 | -2.05 | -1.15 | -1.27 | -1.42 | -0.88 | -0.47 | -0.28 |
| Shares Outstanding | 49.7 | 47.9 | 45.4 | 40.7 | 37.6 | 37.2 | 34.0 | 26.9 | 22.8 | 19.2 | 11.9 | 12.7 | 7.8 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 322.9 | 315.4 | 386.2 | 200.8 | 86.5 | 183.9 | 220.0 | 14.0 | 34.0 | 36.6 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 224.5 | 142.0 | 94.8 | 37.7 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 27.9 | 15.7 | 15.1 | 4.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 13.7 | 12.0 | 8.1 | 2.8 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 589.0 | 485.1 | 504.3 | 245.6 | 86.5 | 184.0 | 220.4 | 15.2 | 35.3 | 38.0 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 20.9 | 6.0 | 7.6 | 1.1 | 0.9 | 1.8 | 0.0 | 0.1 | 0.1 | 0.1 |
| Goodwill | 12.0 | 12.0 | 12.0 | 10.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 40.5 | 46.9 | 53.3 | 59.7 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 27.4 | 18.5 | 11.0 | 14.7 | 0.3 | 0.3 | 0.1 | 0.1 | 0.2 | 0.1 |
| Total Non-Current Assets | 100.8 | 83.4 | 84.0 | 85.8 | 1.3 | 2.1 | 0.2 | 0.2 | 0.3 | 0.2 |
| Total Assets | 689.8 | 568.5 | 588.2 | 331.5 | 87.8 | 186.1 | 220.5 | 15.4 | 35.6 | 38.2 |
| Current Liabilities | ||||||||||
| Account Payables | 65.5 | 72.0 | 40.7 | 38.6 | 13.1 | 13.5 | 10.9 | 3.7 | 3.4 | 4.1 |
| Short-Term Debt | 73.0 | 0 | 0 | 0 | 0 | 0 | 2.6 | 3.3 | 3.3 | 0.3 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.3 | 0 |
| Other Current Liabilities | 203.3 | 36.5 | 76.5 | 17.2 | 4.1 | 0 | 0 | 0 | 0.4 | 0 |
| Total Current Liabilities | 378.8 | 230.1 | 138.9 | 96.6 | 23.1 | 23.4 | 24.5 | 10.8 | 12.2 | 7.2 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 140.9 | 180.7 | 178.1 | 94.3 | 49.1 | 48.3 | 17.3 | 3.6 | 6.7 | 9.5 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 54.4 | 91.7 | 73.3 | 31.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities | 222.7 | 281.4 | 258.4 | 125.4 | 49.1 | 48.9 | 17.3 | 3.6 | 6.7 | 9.5 |
| Total Liabilities | 601.5 | 511.5 | 397.3 | 221.9 | 72.2 | 72.3 | 41.8 | 14.4 | 18.8 | 16.6 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (1,306.0) | (1,122.8) | (835.6) | (596.3) | (409.2) | (278.8) | (175.9) | (107.6) | (76.6) | (47.6) |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 88.3 | 57.0 | 191.0 | 109.6 | 15.6 | 113.8 | 178.7 | 0.9 | 16.7 | 21.6 |
| Total Liabilities & Equity | 689.8 | 568.5 | 588.2 | 331.5 | 87.8 | 186.1 | 220.5 | 15.4 | 35.6 | 38.2 |
| Debt Metrics | ||||||||||
| Total Debt | 241.3 | 193.0 | 186.4 | 94.7 | 49.7 | 50.1 | 19.9 | 6.9 | 9.9 | 9.7 |
| Net Debt | (81.6) | (122.4) | (199.8) | (106.2) | (36.8) | (133.8) | (200.0) | (7.1) | (24.1) | (26.9) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (183.2) | (287.2) | (239.2) | (187.1) | (130.4) | (102.9) | (68.3) | (31.0) | (28.9) | (27.2) |
| Depreciation & Amortization | 9.1 | 8.0 | 6.8 | 4.4 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Stock-Based Compensation | 93.8 | 0 | 62.6 | 37.7 | 20.8 | 14.8 | 6.1 | 1.8 | 2.1 | 2.0 |
| Change in Working Capital | (22.5) | 33.9 | (28.4) | 23.7 | 0.3 | 0.4 | 15.2 | 1.5 | (0.8) | 3.8 |
| Other Non-Cash Items | 9.5 | 116.9 | 53.1 | 4.8 | 1.0 | 8.0 | 0.6 | 0.4 | 0.5 | 0.1 |
| Operating Cash Flow | (93.4) | (128.4) | (145.1) | (116.5) | (108.2) | (78.5) | (46.4) | (30.1) | (26.5) | (21.3) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.5) | (0.3) | (0.6) | (0.7) | (0.3) | (0.0) | (0.0) | (0.0) | (0.0) | (0.1) |
| Acquisitions | 0 | 0 | 0 | (53) | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (0.5) | (0.3) | (0.6) | (53.7) | (0.3) | (0.0) | (0.0) | (0.0) | (0.0) | (0.1) |
| Financing Activities | ||||||||||
| Net Debt Issuance | (7.8) | (1.0) | 85 | 45 | 0 | 28.3 | 12.8 | (3.3) | (0.3) | 10 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (17.1) | 18.0 | (12.7) | (4.2) | 3.7 | (0.1) | 1.4 | 0.5 | 0.5 | (0.1) |
| Financing Cash Flow | 101.5 | 57.8 | 331.0 | 284.6 | 11.1 | 42.4 | 252.4 | 10.0 | 23.9 | 10.0 |
| Cash Position | ||||||||||
| Net Change in Cash | 7.6 | (70.8) | 185.4 | 114.4 | (97.4) | (36.1) | 206.0 | (20.1) | (2.6) | (11.4) |
| Cash at Beginning | 315.4 | 386.2 | 200.8 | 86.5 | 183.9 | 220.0 | 14.0 | 34.0 | 36.6 | 48.0 |
| Cash at End | 322.9 | 315.4 | 386.2 | 200.8 | 86.5 | 183.9 | 220.0 | 14.0 | 34.0 | 36.6 |
| Free Cash Flow | (93.9) | (128.7) | (145.7) | (117.2) | (108.5) | (78.5) | (46.4) | (30.1) | (26.5) | (21.4) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 638.5 | 385.7 | 270.6 | 50.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 591.0 | 352.4 | 244.5 | 44.8 | 0 | 0 | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | 0 | 0 |
| Operating Income | (169.2) | (280.6) | (231.8) | (179.8) | (124.7) | (99.1) | (67.2) | (32.8) | (27.2) | (27.5) | (9.2) | (5.7) | (1.8) |
| Net Income | (183.2) | (287.2) | (239.2) | (187.1) | (130.4) | (102.9) | (68.3) | (31.0) | (28.9) | (27.2) | (12.2) | (6.0) | (2.2) |
| EPS (Diluted) | -3.68 | -5.99 | -5.27 | -4.60 | -3.47 | -2.83 | -2.05 | -1.15 | -1.27 | -1.42 | -0.88 | -0.47 | -0.28 |
| Balance Sheet | |||||||||||||
| Cash & Equivalents | 322.9 | 315.4 | 386.2 | 200.8 | 86.5 | 183.9 | 220.0 | 14.0 | 34.0 | 36.6 | |||
| Total Assets | 689.8 | 568.5 | 588.2 | 331.5 | 87.8 | 186.1 | 220.5 | 15.4 | 35.6 | 38.2 | |||
| Total Debt | 241.3 | 193.0 | 186.4 | 94.7 | 49.7 | 50.1 | 19.9 | 6.9 | 9.9 | 9.7 | |||
| Stockholders' Equity | 88.3 | 57.0 | 191.0 | 109.6 | 15.6 | 113.8 | 178.7 | 0.9 | 16.7 | 21.6 | |||
| Cash Flow | |||||||||||||
| Operating Cash Flow | (93.4) | (128.4) | (145.1) | (116.5) | (108.2) | (78.5) | (46.4) | (30.1) | (26.5) | (21.3) | |||
| Capital Expenditure | (0.5) | (0.3) | (0.6) | (0.7) | (0.3) | (0.0) | (0.0) | (0.0) | (0.0) | (0.1) | |||
| Free Cash Flow | (93.9) | (128.7) | (145.7) | (117.2) | (108.5) | (78.5) | (46.4) | (30.1) | (26.5) | (21.4) | |||